Kailera Therapeutics, Inc. (KLRA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$11.40−$0.5818 (−4.86%) on the dayAs of the close; data may be delayed.
KLRA price, last 12 months
Key stats
- Previous close
- $11.98
- Open
- $11.80
- Day range
- $11.10 – $12.33
- 52-week range
- $11.10 – $28.23
- Volume
- 1.6M
- Avg volume (20 days)
- 1.2M
- Market cap
- $1.5B
Performance
1W−11.2%
1M−38.2%
3M−45.3%
6M—
YTD—
1Y—
Technicals and fundamentals
About Kailera Therapeutics, Inc.
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.5B